Atlas Trials

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Clinical trial NCT02507388 · COMPLETED

Trial details

NCT number
NCT02507388
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration
Start date
2015-08-24
Primary completion
2016-09-06
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.